TOKYO – Alexion Pharmaceuticals Inc. is looking for Japanese approval for its drug, asfotase alfa, to treat patients suffering from hypophosphatasia (HPP), an ultra-rare genetic bone disorder.
NEW DELHI – The Indian drug pricing regulator is caught in a bitter wrangle between the pharmaceutical industry and public health organizations over recent and contradictory government orders that first called for a cap on drug prices and then U-turned.
HONG KONG - A multidisciplinary research team from the Singapore-Massachusetts Institute of Technology (MIT) Alliance in Research and Technology (SMART) has identified a unique set of biophysical markers that are predictive for multipotent mesenchymal stromal cells in bone marrow, which should make it easier to develop stem cell-based therapies.
SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry.
Bionet-Asia Co. Ltd., of Bangkok, provided an update on the company's lead vaccine program at BioJapan 2014, in Yokohama, Japan. The current phase I/II trial in Thailand showed that the vaccine is safe and immunogenic and full results will soon be published in a peer-reviewed journal, Bionet said.
HONG KONG – Biotech stocks have generally avoided the lackluster performance that has characterized stocks in China and Hong Kong in the last quarter. A spate of acquisitions and greater investments in research and development have helped push forward an ongoing consolidation of the market and supported share prices.
SHANGHAI – A Chinese vaccine joint venture (JV), Bravovax Co. Ltd., of Wuhan, has taken on the global rights for a rotavirus vaccine to be administered to newborn infants – the first of its kind to protect infants at birth from potentially life threatening diarrhea leading to severe dehydration.
Shionogi & Co. Ltd., of Osaka, Japan, said S-649266, an investigational parenteral siderophore cephalosporin, exhibited marked potency against gram-negative bacteria, including multidrug-resistant pathogens, in preclinical studies.
Mezzion Pharma Co. Ltd., of Seoul, South Korea, added Jefferson Gregory to its board. He is the chairman and CEO of Rockward Pharmaceuticals, of Bristol, Tenn.
HONG KONG – Scientists from the Institute of Bioengineering and Nanotechnology (IBN) of the Agency for Science, Technology and Research (A*STAR) in Singapore have used an antioxidant extract of green tea to engineer a cancer drug nanocarrier system, which can deliver drugs to kill cancer cells more effectively, while minimizing toxicity to surrounding tissues.
RSS